References
- Writing Group for the Women's Health Initia-tive Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal wo-men: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321–3
- Strickler RC. Women's Health Initiative results: a glass more empty than full. Fertil Steril 2003;80:488–90
- Hersh AL, Stefanik ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. J Am Med Assoc 2004;291:47–53
- Position Statement. Estrogen and progestogen use in pen- and postmenopausal women. Sep-tember 2003 position paper of The North American Menopause Society. Menopause 2003;10:497–506
- Schneider HPG. The view of The International Menopausal Society on The Women's Health Initiative. Climacteric 2002;5:211–16
- Notelovitz M. Editorial: The clinical practice impact of The Women's Health Initiative: political vs biologic correctness. Maturitas 2003;44:3–9
- Gambrell RD Jr, Utian WH. (Letter to Editor and Reply) Menopause 2004;11:236–7
- Yates J, Barrett-Conner E, Barlas S, et al. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteo- porosis risk assessment. Obstet Gynecol 2004;103:440–6
- The Women's Health Initiative Steering Com-mittee. Effect of conjugated equine estrogens in postmenopausal women with hysterectomy. J Am Med Assoc 2004;291:1701–12
- Hully S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605–13
- Anderson GL, Judd HL, Kaunitz AM, et al. Effect of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures. J Am Med Assoc 2003:290:1739–48
- Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350: 1047–59
- Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. J Am Med Assoc 2002;288:2123–9
- Speroff L. A clinician demurs. Sexuality, Repro-duction, and Menopause 2003;1:15–18